RECURRENT HEAD AND NECK CANCER
Clinical trials for RECURRENT HEAD AND NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEAD AND NECK CANCER trials appear
Sign up with your email to follow new studies for RECURRENT HEAD AND NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Sound waves aim to supercharge cancer treatment
Disease control Recruiting nowThis early-stage study is testing whether using ultrasound waves on a tumor can help a standard cancer drug (pembrolizumab) work better. It involves 6 patients with advanced head and neck cancer that has returned or spread. The main goal is to see if combining the drug with this …
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New immune cell therapy combo aims to fight tough head & neck cancers
Disease control Recruiting nowThis study is testing whether a combination of three treatments—a modified immune cell infusion, an immune-stimulating protein, and an approved targeted antibody—is safe and effective for people with advanced head and neck cancer that has returned or spread. It is for patients wh…
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
BioNTech tests new cancer combo in major head & neck trial
Disease control Recruiting nowThis trial is testing whether adding a new drug called BNT113 to a standard immunotherapy (pembrolizumab) works better than the standard treatment alone for people with advanced head and neck cancer linked to HPV16. It aims to see if the combination helps patients live longer and…
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase: PHASE2, PHASE3 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC